Clinton’s Attacks on Drug Prices Leave Health Stocks Reeling

Drugmakers are learning to duck for cover when Hillary Clinton puts them in her sights.

The Democratic presidential nominee’s influence was on display again Wednesday, when she sent Mylan NV’s shares plummeting as much as much as 6.2 percent within minutes of calling for the company to drop prices of its EpiPen emergency allergy shot. It marked the third time over the past year that Clinton’s comments roiled drug stocks.

Read full article